Consumer staples remain a core holding for many portfolios seeking steady demand, pricing power, and relative stability amid late-cycle uncertainty. Here I compare two different ways to access the same broad sector: FXG, the First Trust Consumer Staples AlphaDEX Fund, and IYK, the iShares U.S. Consumer Staples ETF. Both target U.S. consumer staples equities, yet they follow distinct construction rules. FXG applies a multi-factor screening and re-weighting process that leans toward smaller, value-oriented food and distribution businesses, while IYK delivers straightforward market-cap-weighted exposure dominated by well-known mega caps. Understanding these differences helps clarify how each fund may behave in varying market conditions.
FXG tracks the StrataQuant Consumer Staples Index, which uses a modified equal-dollar-weighted approach drawn from the Russell 1000 consumer staples universe. Instead of market-value weighting, the AlphaDEX methodology selects and re-weights stocks based on a blend of growth and value factors. The fund launched in May 2007 and functions as a rules-based smart-beta vehicle rather than a pure cap-weighted tracker. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The portfolio typically holds around 41 securities. Recent top holdings have featured food and distribution names such as PPC, INGR, BG, SFD, GIS, and CASY, along with healthcare-adjacent distributors like MCK. This produces a clear mid-cap tilt, with roughly half the assets in mid-cap companies and notable exposure to protein producers, packaged food, and agricultural processing. FXG carries a 0.63% expense ratio and maintains lower assets under management and trading volume than larger peers.
IYK tracks the Russell 1000 Consumer Staples RIC 22.5/45 Capped Index, a market-capitalization-weighted benchmark with concentration limits. Launched in June 2000 and managed by BlackRock, it offers conventional passive exposure that assigns larger weights to the biggest companies in the sector.
The fund holds roughly 54–58 securities yet remains far more top-heavy than FXG. Leading positions in recent periods have included PG, KO, PM, PEP, MO, MCK, CVS, MDLZ, and CL, with the top ten accounting for about two-thirds of assets. Roughly 85% sits in consumer staples, with secondary healthcare-distribution exposure and a small materials allocation. IYK charges a 0.37% net expense ratio and manages well over $1 billion in assets, supporting stronger liquidity and tighter spreads.
Both funds sit within the consumer staples sector, valued for defensive traits, recurring revenue, and reliable dividends. Recent conditions—elevated inflation, shifting rate expectations, and questions around consumer spending—have drawn attention to companies with strong brands and pricing power. Rising commodity and packaging costs have pressured margins for many packaged-food and beverage names, while weight-loss medications have prompted longer-term questions about calorie consumption. Regulatory scrutiny of tobacco and processed foods continues. In this setting, mega-cap franchises have generally provided steadier earnings visibility, whereas smaller, commodity-sensitive producers—more prominent in FXG—have faced greater cost volatility.
Recent market cycles highlight the impact of their different structures. IYK’s mega-cap brand leaders have delivered more consistent relative results, backed by stable cash flows, global reach, and dividend growth, along with lower beta and smaller drawdowns. FXG has posted weaker and more uneven returns, as its mid-cap holdings proved more sensitive to commodity prices, freight costs, and company-specific surprises. Recent sector rotation toward defensive quality has favored the larger names in IYK, while FXG’s mid-cap exposure added volatility without a clear return offset. The expense-ratio gap of 0.63% versus 0.37% also creates an ongoing performance drag for FXG over longer periods.
When comparing sector ETFs like these, I regularly rely on Tickeron’s AI Screener to quickly filter for technical patterns, fundamentals, and momentum signals across thousands of names. It helps surface relative positioning and trend data that would otherwise require manual effort, allowing a more efficient review of how funds stack up against peers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day moving average for FXG crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where FXG's RSI Indicator exited the oversold zone, 20 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on FXG as a result. In 80 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for FXG just turned positive on October 06, 2026. Looking at past instances where FXG's MACD turned positive, the stock continued to rise in 41 of 47 cases over the following month. The odds of a continued upward trend are 87%.
FXG moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXG advanced for three days, in 258 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
The Aroon Indicator entered an Uptrend today. In 179 of 273 cases where FXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for FXG moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
FXG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category ConsumerStaples